What You Should Know:
- Physicians at the University of California, San Diego
(UCSD) School of Medicine and Cofactor Genomics ink a partnership to improve a
physician’s ability to predict tumor response to immunotherapy, specifically in
recurrent and metastatic squamous cell carcinoma of the head and neck.
- The data generated in this collaboration will further
expand clinical evidence presented by Washington University physicians, where
Cofactor’s technology showed superiority over the
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Uniphore CEO Talks Call Centers & Why Contact Tracing is Failing
Amid the COVID-19 pandemic, all call centers have now been asked to play a vital role, acting as the hubs for contact tracing to help track and contain the spread of the virus. It’s estimated that the U.S. needs to employ 100,000 to 300,000 contact tracers for this to be an effective program. However, call center representatives that have a healthcare background and are trained to handle these sensitive calls are in short supply, so states have had to get “creative about finding the workforce.”
Read More
KPMG Launches COVID-19 Convalescent Plasma Donor Matching Solution
What You Should Know:
- KPMG offers its data & analytics capabilities to
address emerging challenges tied to matching recovered patients with those in
clinical trials to receive convalescent plasma.
- KPMG’s capabilities can make the plasma donation process easier
and more efficient by automating the complex tasks and logistics associated
with the data collection, qualification and matching process by performing
statistical analytics, and using artificial intelligence (AI),
Read More
UK Cancer Diagnostics Startup Biofidelity Raises $12M
What You Should Know:
- UK-based Biofidelity raises $12 million in Series A funding to accelerate the launch of disruptive cancer diagnostic technology.
- The funding will be used to bring technology to market,
enabling a dramatic simplification of precision genetic testing to ensure many
more cancer patients receive optimal diagnosis and therapy.
Biofidelity Ltd, a Cambridge,
UK-based cancer diagnostics company, today announced it has raised $12 million
in Series A funding led by
Read More
Castor Raises $12M to Advance COVID-19 Research Through Clinical Trial and Data Automation
What You Should Know:
- Castor raises $12M in Series A funding to further their
support for COVID-19 research through clinical trial and data automation.
- With 4,000 live studies and 2,000,000 enrolled patients
across 90 countries, Castor will use the funding to further invest in enabling
patient-centric, data-powered clinical trials.
Castor, a Hoboken,
New Jersey startup using automation and data reuse to simplify the entire
clinical trial process, announced $12M in Series A
Read More
THREAD Lands $50M for Decentralized Clinical Trial Research Platform
What You Should Know:
- THREAD receives an additional $50 million capital commitment from Water Street and JLL Partners to expand its decentralized clinical trial research platform
- THREAD is an innovative technology and service
provider that increases participant engagement by enabling pharmaceutical
companies and contract research organizations to remotely capture data from
participants and sites during, in between and in lieu of in-clinic
visits.
- This major investment
Read More
Mission Bio Lands $70M to Expand Cancer Therapies With Single-Cell Multi-Omics Platform
What You Should Know:
- Mission Bio raises $70 million in Series C funding led by
Novo Growth to accelerate the development of cancer therapies with single-cell multi-omics.
- Mission Bio’s Tapestri Platform, the first single-cell platform capable of detecting DNA and protein changes simultaneously, gives a profound insight into the mutations that drive disease to accelerate the development of novel treatments and save patient lives.
Mission Bio,
Inc., a South San Francisco,
Read More
Bayer, Verizon Partner to Build Next-Gen Global Network Infrastructure
What You Should Know:
- Bayer announced that it has chosen Verizon
Business to build a next-gen global network infrastructure to support the
pharmaceutical giant’s global business operations.
- Verizon will enhance Bayer’s existing network
capabilities to enable easier and more cost-effective network management and
will deploy next-generation network technologies, such as software-defined
networking (SDN), to further improve resilience, flexibility,
Read More
Reify Health Raises $30M to Fix The Broken Clinical Trial Ecosystem
What You Should Know:
- Reify Health, a clinical trial software provider
that digitizes and accelerates clinical trials is announcing a $30 million
series B funding round to support the company’s ambitious mission to fix the
broken clinical trial ecosystem.
- The company’s platform, StudyTeam systematically
eliminates redundant work across the clinical trial process while generating
novel insights that speed up trials.
StudyTeam harmonizes biopharma and research
Read More
Moderna Leverages AWS Cloud Platform to Develop New Class of Vaccines and Therapeutics
What You Should Know:
- Moderna, Inc., a biotechnology company pioneering a new
class of messenger RNA (mRNA) medicines, has selected Amazon Web Services
(AWS) as its preferred cloud provider, as well as its standard for
analytics and machine learning workloads.
- By building and scaling its operations on AWS, Moderna
is able to quickly design research experiments and uncover new insights,
automate its laboratory and manufacturing processes to enhance its drug
discovery
Read More
